Antiparasitic drug suramin inhibits SARS-CoV-2 replication and decreases viral load in cell culture. It acts on early steps of SARS-CoV-2 replication, likely viral entry. Suramin demonstrates potent anti-viral efficacy against SARS-CoV-2 in a primary human epithelial airway cell infection model..